Stifel Financial Corp. announced that Dae Gon Ha, Ph.D., has joined the firm as a Director and Equity Research Analyst covering the biotechnology sector. He is based in the firm’s Boston office. Dr. Ha most recently served as a Vice President in biotechnology research at BTIG. Prior to BTIG, he was Vice President in biotechnology research at SVB Leerink, where he focused on rare disease companies. Dr. Ha completed his post-doctoral research fellowship at Harvard Medical School, where he initiated, designed, and executed a chemical compound screen with the goal of identifying novel antibiotics.